comparemela.com
Home
Live Updates
Pieter Reitsma - Breaking News
Pages:
Latest Breaking News On - Pieter reitsma - Page 2 : comparemela.com
First Subjects Dosed in First-in-Human Trial for VarmX s Anticoagulant Reversal Agent, VMX-C001
Trial will assess safety, tolerability, PK and PD of VMX-C001 Major corporate milestone achieved as VarmX transitions into a clinical-stage company VarmX, a clinical-stage biotech company
Pieter reitsma
Kostenloser wertpapierhandel
Melanie toyne sewell katie duffell
Fxa doacs
European innovation council
Leiden university medical center
Direct oral anticoagulants
Chief medical officer
Professor pieter reitsma
Factor xa direct oral anticoagulants
Ysios capital
Lundbeckfonden ventures
Biogeneration ventures
Toyne sewell katie duffell
vimarsana © 2020. All Rights Reserved.